# Vonoprazan Evaluation Compared to Standard Triple Therapy in Helicobacter Pylori eRadication

> **NCT06959368** · PHASE4 · RECRUITING · sponsor: **Asian Institute of Gastroenterology, India** · enrollment: 484 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Vonoprazan 20mg, Esomeprazole 40 mg, Amoxicillin 1 g, Clarithromycin 500 mg

## Key facts

- **NCT ID:** NCT06959368
- **Lead sponsor:** Asian Institute of Gastroenterology, India
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-25
- **Primary completion:** 2026-03-25
- **Final completion:** 2026-03-25
- **Target enrollment:** 484 (ESTIMATED)
- **Last updated:** 2025-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06959368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06959368, "Vonoprazan Evaluation Compared to Standard Triple Therapy in Helicobacter Pylori eRadication". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06959368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*